Abstract Sequence variations in the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) gene have been described in many EBV-isolates. To characterize the genomic relationship between Japanese EBV and the EBV isolates of other countries, we analyzed the LMP1 nucleotide sequences in EBV positive cell lines and clinical specimens, including five African Burkitt's lymphoma (BL) cell lines, a Japanese BL cell line, a B-lymphoblastoid cell line, a nasopharyngeal carcinoma hybrid cell line, six gastric carcinoma tissues, two peripheral blood mononuclear cells, and a B95-8 cell line, which contained the prototype EBV genome. We determined the C-terminal nucleotide sequences of LMP1 by PCR-direct sequencing analysis and characterized the sequence variation of Japanese isolates, made a phylogenetic tree from the sequence patterns of LMP1 by a neighbor-joining method. The results indicate that the Japanese EBV isolates are greatly different from the African BL isolates but are closely related to the China 1, which is a strain of Chinese EBV isolates.
Introduction
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus, which is also associated with a variety of neoplastic diseases, some with a distinct geographical incidence [1] . These neoplastic diseases include Burkitt's lymphoma (BL) endemic to equatorial Africa, nasopharyngeal carcinoma (NPC) common to southern China, Mediterranean Africa and Inuit populations. EBV is also associated with a non-neoplastic disease, namely infectious mononucleosis (IM), essentially, limited to adolescents in Western societies. EBV associated gastric carcinoma (GC) is a non-endemic disease and the reported rate is approximately 4-18% of all GCs worldwide [2] . These diseases do not always contain replicating active EBV but instead contain a latently infected stable EBV genome. A latent EBV infection involves the expression of only 3-11 genes that determined three different types of latency [3] . An EBV-encoded latent membrane protein 1 (LMP1), which is considered to be a viral oncoprotein, is expressed in the above pathologies, with the exception of BL and GC. LMP1 can transform rodent fibroblasts [4] , and can induce lymphoma and hyperplasia in transgenic mice [5] , and is also essential for the EBVmediated transformation of B-lymphocytes [6] .
LMP1 consists of a short cytoplasmic N-terminus tail (amino acid: aa. 1-24), six transmembrane domains (aa. , and a long cytoplasmic C-terminus (aa. 187-386), which contains three essential activating domains. LMP1 is known to activate at least seven signaling pathways, in which five of these activations occur through the LMP1 C-terminus: nuclear factor (NF)-jB inducing kinase (NIK) activation of NF-jB, p38/mitogen-activated protein kinase (MAPK) activation of activator transcription factor 2 (ATF-2), Janus kinase (JAK) activation of signal transducer activators of transcription (STAT), c-Jun N-terminal kinase (JNK) activation of AP-1 and the activation of Akt [7] .
Some types of sequence variation of LMP1 were detected in the C-terminus of the gene [8] . Using these variants, Edwards et al. discriminated at least seven distinct EBV strains and described phylogenetic relationship between the strains [9] . Within LMP1, there is an 11 amino-acid repeat element of varying copy numbers, which has been shown to sort independently of the strain [8] , and a 30-base pair (bp) region that is consistently deleted in some strains of EBV [9] . This deletion has been suggested to make transformations more aggressive [10] . On the other hand, the 30 bp deletion has been observed in some variants that are geographically restricted [9] [10] [11] [12] , the details remain unclear regarding the role of this deletion.
To determine whether this 30-bp deletion is derived from a pathogenetic factor or a geographical factor, we analyzed the sequence of the LMP1 C-terminal region from EBV-associated gastric carcinoma specimens, and peripheral blood samples in Japanese patients, cell lines established from Japanese patients, and wellknown BL cell lines established from African BL patients by a direct sequencing method. Our results indicated the identical 30-bp deletion, the unique 33-bp repeat sequences and considerable sequence variations in the C-terminus of LMP1. To investigate the genomic relationship between Japanese EBV and African BL-EBV isolates, we drew a phylogenetic tree by using our data to the LMP1 gene from the previous study [9] , and compared these sequences with each other. We defined that all Japanese EBV isolates are greatly different from African BL isolates, but they closely resemble the China1 strain, which is a group of isolates found in southern China.
Materials and methods

Cells and preparation of DNA
Nine cell lines, B95-8 [13] , P3HR-1 [14] , Raji [15] , EB1 [16] , Namalwa [17] , Daudi [18] , Akata [19] , OB [20] , and NPC-KT [21] , were used in this study. The cell lines were cultured in RPMI1640 medium (Nissui Pharmaceutical Co., Tokyo, Japan) with penicillin (100 IU/ml), streptomycin (100 lg/ml), and fetal bovine serum (10%) in CO 2 incubator at 37°C.
GC tumor region specimens were dissected from the stomachs removed at surgery. GC1, GC2, and GC3 were obtained from hospitals in Yonago (the western part of Honshu-island, Japan), while GC4, GC5, and GC6 were obtained from hospitals in Sendai (the northern part of the Honshu-island, Japan). The GC portions of the samples were all EBV genome positive based on by polymerase chain reaction (PCR) findings using a Bam HI-W specific primer pair [22] and by in situ hybridization for EBV-encoded small RNA (EBER) [23] .
The patients' peripheral blood mononuclear cells (PBMCs) with a high load of EBV DNA were obtained four hospitals in Yonago and Tokyo, Japan. The PBMCs were isolated using Lymphosepare I (ImmunoBiological Lab. Co., Fujioka, Japan).
Tissue or cells was digested with proteinase K (100 lg/ml) in 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM EDTA, and 0.1% SDS at 55°C for 90 min. DNA was extracted from the digest with phenol/chloroform and precipitated by ethanol, and dissolved in TE (10 mM Tris-HCl, pH 8.0, 1 mM EDTA) as described previously [24] .
Direct sequencing of PCR products to LMP1 gene Nested PCR was performed using three primers (Table 1 ). In the 1st round PCR, 5 ng of the DNA samples were used as templates. A total of 500 mol LM-SS1, LM-SA2 primers, 1 unit of Ex Taq polymerase (Takara Bio Inc., Ohtsu, Japan), and 250 lM dNTP mixture were added and filled up to 10 ll with H 2 O. PCR was then performed in one cycle for 5 min at 94°C, 30 s at 54°C, and 1 min at 72°C, and in 24-34 cycles for 30 s at 94°C, 54°C, and 1 min 72°C, respectively, using the PCR thermal cycler MP TP3000 (Takara). The PCR products were subjected to electrophoresis on 1.8% agarose gel, confirmed based on their size, and then, 1000-fold diluted PCR products were used for the 2nd round PCR. The 2nd round PCR was carried out as described above except for primers LM-SS3 and LM-SA2, and thermal cycles consisting of one cycle for 5 min at 94°C, 30 s at 58°C and 1 min at 72°C, and 14-24 cycles for 30 s at 94°C, 58°C and 1 min at 72°C. These PCR products were purified by a MinElute gel extraction kit (Qiagen Co., Hilden, Germany) and then were used as templates of a cycle sequence reaction. The cycle sequence reaction was performed by a reaction mixture which contained 10-50 ng of these templates, 4 ll of Big Dye Terminator Cycle Sequencing FS Ready Reaction (Applied Biosystems Co., Foster, USA) and 2 ll of LM-SS3 or LM-SA2 (diluted to 0.8 pmol/ll each) and filled up to 10 ll with H 2 O. A cycle sequencing reaction was carried out at 25 cycles for 10 s at 96°C, 10 s at 50°C, and 4 min at 60°C. The cycle sequence products were purified by Sephadex G-50 DNA Grade F (Amersham Biosciences Ltd., Buckinghamshire, UK) and their sequence determined were by the Genetic Analyzer 3100 (Applied Biosystems). The sequence data were checked for any homology in BLAST (National Center for Biotechnology Information: NCBI; http://www. ncbi.nlm.nih.gov/) and any alignments between these data were analyzed using Genetyx-SV RC version 6 (Genetyx Co., Tokyo, Japan).
Phylogenetic analysis
To analyze the phylogenetic relationship within the EBV sequence samples, the LMP1 sequence, including codons 241-386, was compiled from our 17 samples. The sequences were aligned and the distances between each sample were calculated with the ClustalW home page (DNA Data Bank of Japan: DDBJ; http:// www.ddbj.nig.ac.jp/search/clustalwj.html), using JukesCantor and Kimura two-parameter model. A phylogenetic tree was constructed from these matrices by the neighbor-joining method [25] using the Phylogenetic Tree Printer (Phylodendron: http://iubio.bio.indiana.edu/treeapp/) from the PHYLIP formatted file.
Results
Analysis of the C-terminal nucleotide sequences
We determined the nucleotide (nu.) sequence 168154-168594 of LMP1 gene in EBV isolates by direct sequencing of the PCR products. Firstly, we confirmed that the sequences of B95-8, Raji and Akata were identical to the data in the NCBI (Nucleotide: D10059, AF093534) (Fig. 1) . We compared our data with the EBV genome standard B95-8, using Genetyx SV/RC ver.6.1 in this study.
Identification of the 30-bp deletion
The 30-bp deletion (nu: 168256-168285) in LMP1 gene is detected on many EBV isolates [8, 11, 12] . This deletion was detected in all EBV DNA specimens from a Japanese BL cell line Akata, a B-lymphoblastoid cell line OB from a patient with atopic dermatitis, and a NPC cell line NPC-KT; however, it was not detected in them from B95-8, or from the African BL derived cell lines Raji, P3HR-1, EB1, Namalwa and Daudi (Fig. 1) . The same deletion was detected in all EBV DNA specimens from six GC tissues and 2
PBMCs obtained from Japanese patients. These results indicate that this deletion is found in the majority of Japanese isolates.
Variation in the 11 amino acids repeat element in LMP1
A varying number of repeats with an 11 amino acid element (PQDPDNTDDNG) are present between the 253rd and 306th amino acids in the C-terminal domain of LMP1 [7] . The B95-8 strain has four perfect repeats of the 11 amino acid element and a 5 amino acid sequence (PHDPL: 275-279) insertion between the 2nd and the 3rd repeats (Fig. 2) . The five amino acid sequence is also repeated at position in the following sequence (aa: 302-306).
The same repeat structure of B95-8 was also observed in Raji and P3HR-1. EB1 and Namalwa had 2, Daudi had 3 times perfect repeats of the 11 amino acid sequence, but they did not have the 5 amino acid insertion. And EB1 had 3, Namalwa had 2 and Daudi had 1 time of 11 amino acid sequence PQGPD NTDDNG that has an amino acid, which is changed from D to G by point mutations.
A Japanese isolate OB had 5 perfect repeats of 11 amino acid sequence and 5 amino acid sequence between the 3rd and 4th repeat, and the 5 amino acid sequence at the end. All other Japanese isolates had 4-6 perfect repeats of amino acid sequence but not the 5 Fig. 2 A schematic diagram of the variation in the 11 amino acid repeat element in the C-terminal of LMP1. Across the top, the pattern of the 11 amino acid repeat element of B95-8 prototype is shown with the number which shows the LMP1 amino acid positions of both sides. The names in the left column refer to the individual isolates, (J) indicates the Japanese isolates, and the patterns of the repeat sequences are indicated. The numbers of amino acid residues of those regions are shown in parenthesis in the rightmost column amino acid insertion, with the 5 amino acid sequence at the end. These findings indicate that Japanese EBV isolates, except for OB, had a resembled variation that was different from the B95-8 and African BL isolates regarding the repeat element in LMP1.
Sequence variations in the C-terminus of LMP1
Considerable nucleotide-sequence variations among different EBV isolates are also detected within the C-terminal region of LMP1 [8, 9, 11, 12] . Cases of common mutations in more than two samples were as follows ( Fig. 1): In 168566, EB1, Namalwa, and Daudi had a mutation from <g> to <c> (aa: G to A in 252). In 168476, EB1 and Namalwa mutated from <a> to <g> (aa: D to G in 282). In 168443, EB1, Namalwa and Daudi mutated from <a> to <g> (aa: D to G in 293). In 168395, every samples except P3HR-1 mutated from <g> to <a> (aa: S to N in 309). In 168374, GC1 and GC5 mutated from <a> to <g> (aa: N to S in 316).
It was shown that mutations occurred frequently between 168357 and 168355 [8, 9] . In 168357, Namalwa and Daudi mutated from <c> to <g> (aa: Q to E in 322), Akata, OB, GC1, GC2, GC3, GC4, GC5, GC6, PBMC1 and PBMC2 mutated from <c> to <a>. In 168355, most Japanese isolates mutated from <a> to <t> (aa: Q to N in 322, but NPC-KT mutated from Q to H, and GC2 mutated from Q to I).
In 168345, GC1, GC4, GC6 had a mutation from <g> to <c> (aa: E to Q in 326). In 168336, PBMC1 and PBMC2 mutated from <a> to <c> (aa: N to H in 329). In 168332, GC2 and PBMC2 mutated from <a> to <g> (aa: K to R in 330).
In 168320, every sample except of Raji, P3HR-1 and EB1 mutated from <a> to <g> (aa: Q to R in 334), and in 168308, they mutated from <t> to <c> (aa: L to S in 338). In 168295, every sample except Raji and Akata changed from <a> to <t> (silent mutation). In 168266, Namalwa and Daudi mutated from <a> to <g> (aa: H to R in 352). In 168225, every sample mutated from <t> to <a> (aa: S to T in 366).
Most Japanese specimens had common mutations in 168395, 168357, 168355, 168320, 168308, 168295, 168225 and 30-bp deletion (168285 to 168256). The mutation from <a> to <t> in 168355 was detected in all Japanese isolates, but not in all African BL isolates. The mutation from <c> to <a> in 168357 was also observed in all Japanese isolates except in NPC-KT. These mutations were also reported in the China EBV isolates described in previous reports [8, 9] .
Phylogenetic tree analysis
Using variations of the C-terminus of LMP1, EBV strains were classified into seven strains: Alaskan, NC, B95-8, Mediterranean (Med), China 1, China 2, and China 3 strains [8, 9] . To assign the Japanese EBV isolates, a phylogenetic tree was drawn, using nucleotide sequence 168154-168594 (Fig. 3) .
P3HR-1, EB1 and Raji, Namalwa and Daudi derived from African BL were included in the same branch, respectively. B95-8 strain is located on an extension of the P3HR-1 branch. All Japanese isolates were included in a branch that was clearly different from the branch of African BL and B95-8 EBV isolates.
Discussion
LMP1 is essential for the transformation of B-lymphocytes [6] . Numerous studies have been made based on its deletion [10] [11] [12] 26] . The 30-bp deletion mutant in the C-terminal region of the LMP1 gene has been reported to have a strong potential to transform rodent cell and B-lymphocyte and it was also found to be closely associated with NPC [26] [27] [28] . The 30-bp sequence in C-terminus of LMP1 is thus suggested to play an important role in the process of oncogenesis [10] . On the other hand, the 30-bp deletion in C-terminus of LMP1 has been reported to be one of the characteristics of the major EBV strain distributed in eastern Asia [9] and Japan [11, 12] . In this study, we detected the 30-bp deletion in the C-terminus of LMP1 in all EBV isolates in Japan. This deletion was found at position 168256-168285, and our findings are identical to previous reports [11, 12] (Fig. 1.) . The 30-bp deletion was observed not only in epithelial cancers such as GC specimens or a NPC-KT cell line derived from Japanese NPC, but also in EBV infected PBMC specimens from non-malignant patients, a BL cell line Akata and a B lymphoblastoid cell line OB in Japanese. These results suggest that the EBV strain with the 30-bp deletion is found frequently in Japan regardless of the infection in malignant or non-malignant diseases. For instance GC1, GC2, and GC3 were obtained from a hospital in the Yonago area (the western part of Honshu-island) and GC4, GC5 and GC6 were obtained from the Sendai area (the northern part of Honshu-island), while PBMC1 and PBMC2 were obtained in Tokyo (the middle part of Honshu-island) and Yonago, respectively.
We herein confirmed the previous finding that isolates of B95-8, Raji and P3HR-1 have 4 perfect repeats with the 11 amino acid sequence (PQDPDNTDDNG) and with the insertion of 5 amino acids (PHDPL) between the 2nd and the 3rd repeats [7, 8] and added new information indicating the isolates of EB1, Namalwa and Daudi to have 2-3 times perfect repeats and 1-3 imperfect repeats (PQGPDNTDDNG) but did not have the inserted 5 amino acids (Fig. 2) . We found all Japanese, except OB, to have 4-6 times perfect repeats of the 11 amino acid sequence but did not have the insertion of a 5 amino acid in the sequence. OB isolate has 5 perfect repeats with a 5 amino acid sequence. The variation in the repeat number and the insertion of a 5 amino acid sequence between repeats was thus suggested to arise by recombination during the replication of the virus [8] . Our results indicate that all Japanese isolates, except for the OB isolate, are clearly different from the B95-8 and African BL isolates. The distinctive relationship of the domain of LMP1 may thus suggest a difference in the EBV strains regarding the geographic location.
The C-terminal sequence of LMP1 distinguishes 7 distinct sequence patterns or strains. These strains can be perfectly discriminated at more than 7 loci [9] . The change at amino acid 322 is particularly informative with an asparagine present in China 1, a glutamic acid in Med, a lysine in Alaskan, a threonine in NC, and a glutamine in B95-8, China 2, or China 3 strains. In this study, although we did not investigate amino acid 229, the common region sequences except for the repeat region of 16 samples (168417-168163) were obtained, and these were compared with the B95-8 prototype strain (Fig. 1) . The pattern of polymorphisms from Japanese EBV isolates was very similar to each other. Mutations at 168395, 168357, 168355, 168320, 168308, 168295, 168225, and the 30-bp deletion, were common among Japanese samples, although GC2 had more mutations at 168356, while NPC-KT did not have any mutation at 168357, and Akata had a different mutation at 168295. These base pair changes correspond to the amino acid changes at position 309 S to N, 322 Q to N or Q to H or Q to I, 334 Q to R, 338 L to S, and 366 S to T, and the deletion 346-355, with silent mutations at 342. These patterns of polymorphisms suggested that most Japanese EBV isolates are very similar to the China 1 strain, and we found that Raji, P3HR-1 and EB1 are similar to the B95-8 strain, and Namalwa and Daudi to Med strain, respectively [8, 9] . According to the polymorphic resemblance on cell lines, Raji [15] and P3HR-1 [14] , a clone of Jijoye cell lines [29] , EB1 [16] , Daudi [30] , and Namalwa [17] cell lines were established from BL patients of Nigeria, Uganda and Kenya, respectively. B95-8 EBV originated in an IM patient from the United States of America [13] .
To show the strain variations between Japanese and African BL isolates more clearly, we analyzed the phylogenetic tree, and drew the EBV isolates on it (Fig. 3) . The phylogenetic tree showed the Raji, EB1 and P3HR-1 EBV isolates to be in the same branch. The B95-8 strain is located on an extension of the P3HR-1 strain, whereas Namalwa and Daudi are located on the Med strain. The Japanese EBV isolates were found on the same branches that belonged to the branch of China 1, which thus correlated with the results of similar studies for NPC isolates [9, 31] . These results indicate that the EBV strains distributed in Japan are genetically distant from those of African BL and close to the China 1 of Chinese strains.
From our results and previous reports in the literature, we hypothesized that EBV might thus have mutated along with racial migration all over the world. From the viewpoint of geographic location, this hypothesis is very attractive regarding the relationship of EBV strains and geographic locations.
Although the 30-bp deletion is extensively distributed all over the world, the existence ratio is greatly restricted due to geographical locations and racial elements. It is not detected at all from the BL isolates of the Negroid origin (Fig. 1) , while only low values are found from Caucasian origin in comparison to Mongoloid origin [32] [33] [34] . It was dominantly detected in areas where Mongoloids reside such as Japan [11, 12] and China [33] , Korea [28, 35] , Taiwan [36] , Malaysia [26, 37] , Brazil [38, 39] , and in ethnic groups along the Arctic Circle (Inuit) [33] . On the other hand, the high ratio of 30-bp deletion is not always detected in areas in which Mongoloids are distributed with a high frequency. There have been reports on both a high frequency [40] and a low frequency [34] of 30-bp deletion in Argentina. In addition, Chinese such as isolates China 2 and China 3 do not have the 30-bp deletion, and a part of Inuit classified as Mongoloids are infected with Alaskan strain EBV without the 30-bp deletion [9] . As a result, no direct relationship was found between a 30-bp deletion and polymorphisms based on these findings, and simple racial distinctions are also difficult to make. Recently, Burrows et al. showed southeast Asian isolates to have evolved as a lineage distinct from those of Papua New Guinea, Africa, and Australian isolates [31] . The LMP1 C-terminal may therefore potentially allow us to elucidate the evolution of EBV in humans.
